USPTO serial 79089375
CYTOTUNE
Reviewed by CopyMark Law Group
Reg. 4095058Status 706Registered
- Filing date
- Status date
- Registration date
- Feb 7, 2012
- Examiner
- DE JONGE, KATHLEEN
- Law office
- GENERIC WEB UPDATE
What this means
This trademark is registered with the USPTO. Monitoring new filings can help you catch lookalike marks early.
Need help with CYTOTUNE?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Stacey R. Halpern
Stacey R. Halpern KNOBBE MARTENS OLSON & BEAR LLP2040 Main Street, 14th FloorIrvine, CA 92614UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Chemical reagents not for medical or veterinary purposes; [ protein in raw material form for scientific and medical research; enzymes for scientific and medical research; biochemicals, namely, polypeptides for in vitro and in vivo scientific and research use; ] biochemicals, namely, polynucleotides for in vitro and in vivo scientific and research use [ ; chemical reagents comprising antibodies not for medical or veterinary purposes; chemical agents for chelating and sequestering; higher fatty acids for use in the field of scientific research, reagents, cosmetics, and pharmaceuticals ] | ACTIVE | — |
| 005 | [ Anti-cancer preparations; anti-sarcoma preparations; contrasting agent for X-ray imaging; diagnostic reagents for medical purposes; radio-isotope markers for therapeutic or diagnostic use; veterinary preparations for veterinary vaccines; biological preparations for the treatment of cancer, critical limb ischemia, cystic fibrosis, retinitis pigmentosa, AIDS, influenza, and Alzheimer's disease; preparations for gene therapy, namely, introducing genes to human and animal cells, tissues, organs and living bodies, and growth media for medical purposes; vaccines; gene vaccines; vectors for introducing genes to human and animal cells, tissues, organs and living bodies, and growth media for medical use, namely, for gene therapy ] | SECTION 71 - CANCELLED | — |
| 042 | [ Testing, inspection, research, or development of pharmaceuticals, cosmetics, or foodstuff; testing, inspection, research, or development of pharmaceutical preparations for gene therapy; testing, inspection, research, or development of vaccines; testing, inspection, research, or development of recombinant proteins; medical, chemical, biochemical, biological and bacteriological research and functional analysis of genes or proteins; testing, inspection, or research related to technologies for manufacturing genetically engineered animals, plants, and vectors; testing, inspection, research, or development of vector technologies, namely, medical and scientific research in the field of genetics and genetic engineering; testing, inspection, or research on agriculture, livestock breeding, or fisheries; testing, inspection, research, or development of chemicals for life science ] | SECTION 71 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by DNAVEC CORPORATION
- Other trademarks owned by DNAVEC CORPORATION
- Other trademarks owned by ID Pharma Co., Ltd.
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 042
- Similar marks named CYTOTUNE
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| May 3, 2025 | Further Decision Processed by IB | — | |
| Mar 7, 2025 | XXSS | GENERIC MADRID TRANSACTION SENT TO IB | — |
| Mar 7, 2025 | INNA | INVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE | — |
| Mar 7, 2025 | XXCR | GENERIC MADRID TRANSACTION CREATED | — |
| Mar 13, 2023 | INPR | PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED | — |
| Jul 13, 2022 | NA71 | NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED | — |
| Jul 13, 2022 | 71AG | REGISTERED-SEC.71 ACCEPTED | — |
| Jul 11, 2022 | ES71 | TEAS SECTION 71 RECEIVED | — |
| Feb 7, 2021 | REM4 | COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED | — |
| Sep 14, 2020 | RNWL | INTERNATIONAL REGISTRATION RENEWED | — |
| Dec 6, 2019 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| May 10, 2019 | INNP | PARTIAL INVALIDATION PROCESSED BY THE IB | — |
| Mar 19, 2019 | INPS | PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB | — |
| Mar 19, 2019 | INPC | INVALIDATION PROCESSED | — |
| Mar 13, 2019 | INPR | PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED | — |
| Jan 5, 2019 | RFNP | REFUSAL PROCESSED BY IB | — |
| Jul 13, 2018 | NA75 | NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED | — |
| Jul 13, 2018 | C75P | REGISTERED - PARTIAL SEC. 71 ACCEPTED & SEC. 15 ACK. | — |
| Jul 13, 2018 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Jun 18, 2018 | ES75 | TEAS SECTION 71 & 15 RECEIVED | — |
| Feb 7, 2017 | REM3 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED | — |
| Oct 1, 2015 | ADCH | CHANGE OF NAME/ADDRESS REC'D FROM IB | — |
| Jul 28, 2012 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Jul 6, 2012 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Jul 6, 2012 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Jun 30, 2012 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| May 7, 2012 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Feb 7, 2012 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Nov 22, 2011 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Nov 22, 2011 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Nov 3, 2011 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Nov 2, 2011 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Nov 2, 2011 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Oct 18, 2011 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Oct 18, 2011 | ATRV | ATTORNEY REVIEW COMPLETED | — |
| Oct 17, 2011 | LIMS | LIMITATION OF GOODS/SERVICES FROM IB ENTERED | — |
| Oct 13, 2011 | ALIE | ASSIGNED TO LIE | — |
| Oct 8, 2011 | LIMG | LIMITATION OF GOODS RECEIVED FROM IB | — |
| Sep 23, 2011 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Sep 22, 2011 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Sep 21, 2011 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Sep 21, 2011 | ERFR | TEAS REQUEST FOR RECONSIDERATION RECEIVED | — |
| Sep 7, 2011 | CORN | CORRECTION FROM THE IB EXAMINED, NO ACTION IS NEEDED | — |
| Sep 2, 2011 | CRCV | CORRECTION TRANSACTION RECEIVED FROM IB | — |
| Jun 1, 2011 | GNS1 | NOTIFICATION OF SUBSEQUENT FINAL EMAILED | — |
| Jun 1, 2011 | GNSF | SUBSEQUENT FINAL EMAILED | — |
| Jun 1, 2011 | CFRC | SUBSEQUENT FINAL REFUSAL WRITTEN | — |
| Jun 1, 2011 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Jun 1, 2011 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Jun 1, 2011 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| May 25, 2011 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| May 25, 2011 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| May 25, 2011 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Apr 6, 2011 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Apr 6, 2011 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Dec 18, 2010 | RFNT | REFUSAL PROCESSED BY IB | — |
| Nov 30, 2010 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Nov 30, 2010 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Nov 30, 2010 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Nov 29, 2010 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Nov 28, 2010 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Nov 26, 2010 | DOCK | ASSIGNED TO EXAMINER | — |
| Nov 26, 2010 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Nov 25, 2010 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |